Fibroblast binding agents and use thereof
US11896643B2 · kind B2 · utility
0Cited by
60References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2019 |
| Grant date | Feb 13, 2024 |
| Priority date | — |
| Expiry date | Dec 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to agents that bind fibroblast activation protein (FAP) and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the FAP binding agents and their use in the treatment of various diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.